Clinical Trial Update: Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab with docetaxel and radiation therapy in patients with stage III or stage IV head and neck cancer. Results were com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-06-09